1. Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents
   Chen Zhou et al, 2024, Journal of Medicinal Chemistry CrossRef
2. Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs
   Maxime Liberelle et al, 2022, Journal of Medicinal Chemistry CrossRef
3. The deadly cross-talk between Hippo pathway and epithelial–mesenchymal transition (EMT) in cancer
   Ioanna Akrida et al, 2022, Molecular Biology Reports CrossRef
4. Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management
   Noha M. Hany et al, 2022, Journal of Translational Medicine CrossRef
5. The Role of TEAD2 in Malignant Tumors and Research Progress
   若卿 吴, 2023, Advances in Clinical Medicine CrossRef
6. The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
   Richard Cunningham et al, 2022, Clinical Science CrossRef
7. TEAD4 as an Oncogene and a Mitochondrial Modulator
   Sheng-Chieh Hsu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef